Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Možnosti terapevtske uporabe nanodelcev s strukturo tekočih kristalov kot dostavnih sistemov zdravilnih učinkovin
Authors:ID Prašnikar, Monika (Author)
ID Vitek, Mercedes (Author)
ID Gosenca Matjaž, Mirjam (Author)
Files:.pdf PDF - Presentation file, download (1,11 MB)
MD5: 0B3F744B3DA55D84AFC6D203EF929F8F
 
URL URL - Source URL, visit https://www.sfd.si/vestnik/farmacevtski-vestnik-5-stevilka-2025/
 
Language:Slovenian
Typology:1.02 - Review Article
Organization:Logo SFD - Slovenian Pharmaceutical Society
Abstract:Nanodelci s strukturo tekočih kristalov so termodinamsko stabilni nanodostavni sistemi z urejeno strukturo, ki združujejo lastnosti kristalnih trdnih snovi in tekočin. Njihova edinstvena struktura omogoča vgradnjo hidrofilnih, amfifilnih in hidrofobnih zdravilnih učinkovin. Najpogostejše prednosti vgradnje zdravilnih učinkovin v nanodelce s strukturo tekočih kristalov, ki jih lahko oblikujemo za različne načine aplikacije, so zaščita zdravilne učinkovine, prirejeno sproščanje in izboljšana biološka uporabnost. Za peroralno aplikacijo vgrajujemo zdravilne učinkovine v nanodelce s strukturo tekočih kristalov z namenom izboljšanja absorpcije in biološke uporabnosti slabo topnih zdravilnih učinkovin, zaščite nestabilnih zdravilnih učinkovin ali preprečevanja neželenih učinkov. Pri dermalni uporabi sta izraziti prednosti nanodelcev s strukturo tekočih kristalov prirejeno sproščanje in izboljšana permeabilnost zdravilnih učinkovin v globlje plasti tkiva. hkrati nanodelci s strukturo tekočih kristalov omogočajo ciljano zdravljenje raka ali bolezni možganov in prinašajo nove priložnosti dostave cepiv in bioloških učinkovin, kot so proteini, peptidi in nukleinske kisline. Preboj teh nanodelcev v klinično uporabo upočasnjuje predvsem nepredvidljiva kinetika sproščanja zdravilnih učinkovin in pomanjkanje biorelevantnih modelov in študij. Kljub temu so nanodelci s strukturo tekočih kristalov raznovrsten dostavni sistem, ki ponuja priložnost za oblikovanje dostopnih in pacientu prijaznih zdravil.
Keywords:heksosomi, kubosomi, metode izdelave, na lipidih osnovani dostavni sistemi, načini aplikacije, nanodelci, tekoči kristali
Publication status:Published
Publication version:Version of Record
Publication date:01.12.2025
Year of publishing:2025
Number of pages:str. 327-339
Numbering:Letn. 76, št. 5
PID:20.500.12556/DiRROS-27583 New window
UDC:66.017-022.513.2:620.3
ISSN on article:2536-4316
COBISS.SI-ID:266069507 New window
Note:Nasl. z nasl. zaslona; Besedilo v slov.; Opis vira z dne 26. 1. 2026;
Publication date in DiRROS:13.02.2026
Views:339
Downloads:117
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Farmacevtski vestnik : strokovno glasilo slovenske farmacije
Publisher:Slovensko farmacevtsko društvo
ISSN:2536-4316
COBISS.SI-ID:288686336 New window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Secondary language

Language:English
Title:Therapeutic possibilities of liquid crystalline nanoparticles as drug delivery systems
Abstract:Liquid crystalline nanoparticles are thermodynamically stable nanodelivery systems with an ordered structure, combining the properties of crystalline matter and liquids. Their unique structure enables incorporation of hydrophilic, amphiphilic, and hydrophobic active pharmaceutical ingredients. Their protection, controlled release, and enhanced bioavailability are the most common advantages of liquid crystalline nanoparticles, which can be tailored for various routes of administration. In oral delivery, active pharmaceutical ingredients are incorporated into liquid crystalline nanoparticles to improve their absorption and bioavailability, protect unstable active pharmaceutical ingredients, or prevent their side effects. For dermal application, controlled release and enhanced permeability of active pharmaceutical ingredients into deeper tissue layers are key advantages. Moreover, liquid crystalline nanoparticles enable targeted therapy for cancer and brain diseases and offer new opportunities for the delivery of vaccines and biological active substances such as proteins, peptides, and nucleic acids. however, clinical translation of these nanoparticles is hindered primarily by burst release kinetics and a lack of biorelevant models and studies. Despite these challenges, liquid crystalline nanoparticles represent a versatile delivery platform with the potential to develop accessible and patient-friendly medicines.
Keywords:administration routes, cubosomes, hexosomes, lipid-based delivery systems, liquid crystals, nanoparticles, preparation methods


Collection

This document is a part of these collections:
  1. Farmacevtski vestnik

Back